{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":29,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":29,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"53650d73b94e","filters":{"venue":"Human Vaccines"}},"results":[{"id":"W2114391710","doi":"10.4161/hv.5.10.9518","title":"Comparison of the immunogenicity and safety of<i>Cervarix</i>™ and<i>Gardasil</i><sup>®</sup>human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years","year":2009,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gardasil; Medicine; Vaccination; Immunogenicity; HPV vaccines; Cervical cancer; Titer; Cohort; HPV infection; Virology; Immunology; Cancer; Internal medicine; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.0458395217292541,"gpt":0.3782813287635329,"spread":0.3324418070342788,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005385571,0.0002783407,0.001066359,0.0001972702,0.0002212425,0.00002504227,0.0002924745,0.0001755117,0.002190043],"category_scores_gemma":[0.00006676972,0.0002095704,0.0001359676,0.0004801886,0.0001202998,0.00009157595,0.0002168789,0.0005986769,0.000001888302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001793509,"about_ca_system_score_gemma":0.0001421875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002152884,"about_ca_topic_score_gemma":0.001928833,"domain_scores_codex":[0.9974273,0.0001957119,0.0008997978,0.0004488537,0.0004781274,0.0005502442],"domain_scores_gemma":[0.9986962,0.0001225405,0.0002096606,0.0005517278,0.0001745633,0.0002452887],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004126088,0.0006360682,0.944816,0.0007086686,0.0001198141,0.000009336998,0.004727154,0.00004661122,0.006882072,0.0003543601,0.0007986695,0.03677515],"study_design_scores_gemma":[0.00646153,0.00102286,0.9888549,0.0001060195,0.00006469477,0.000009134113,0.0005524266,0.0001205563,0.001083613,0.0005119877,0.001021235,0.0001910097],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903712,0.006482237,0.000001793433,0.001046721,0.00004244233,0.0007031136,0.00003058172,0.0000316271,0.001290335],"genre_scores_gemma":[0.9977852,0.001009201,0.00002799644,0.000640129,0.0001785444,0.00003798627,0.00001305869,0.00002833557,0.000279618],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04403892,"threshold_uncertainty_score":0.9987221,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017096286","doi":"10.4161/hv.7.12.18322","title":"Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier universitaire de Québec; University of Alberta","funders":"Merck","keywords":"Medicine; Immunogenicity; Schedule; Titer; Internal medicine; Vaccination; Gastroenterology; Antigen; Antibody; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.08895439800482836,"gpt":0.3512983015467438,"spread":0.2623439035419154,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005528232,0.0003235121,0.0006810758,0.0001439312,0.0004570731,0.00004086736,0.0006123102,0.000125001,0.01483404],"category_scores_gemma":[0.0003444683,0.0001873425,0.0002281,0.0005983757,0.0001031353,0.00008935809,0.0005833828,0.0004760214,0.0001002477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009188864,"about_ca_system_score_gemma":0.0001902724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00101992,"about_ca_topic_score_gemma":0.001944619,"domain_scores_codex":[0.9976476,0.000189624,0.0006629394,0.0004842106,0.0004991105,0.0005164914],"domain_scores_gemma":[0.9975923,0.0001233851,0.0001816629,0.001268534,0.0005142307,0.0003199222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1365645,0.008358134,0.4626642,0.003614294,0.003994772,0.0001882657,0.03015313,0.00001673768,0.1878573,0.01344341,0.06552541,0.0876198],"study_design_scores_gemma":[0.009252402,0.0008961519,0.9581746,0.000097528,0.0002078662,0.00007290703,0.0008637692,0.00009793056,0.02155748,0.0003120464,0.00822839,0.0002388834],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758766,0.001676536,0.00001649219,0.002463739,0.000146431,0.001528564,0.00003397286,0.00006765782,0.01818998],"genre_scores_gemma":[0.9961038,0.00008577582,0.0001570246,0.001120052,0.0002473541,0.00006809401,0.00002785617,0.00004828966,0.002141811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4955104,"threshold_uncertainty_score":0.9860665,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073044683","doi":"10.4161/hv.5.2.7210","title":"BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacy","year":2009,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"Virulence; Mycobacterium bovis; Mycobacterium tuberculosis; BCG vaccine; Tuberculosis vaccines; Tuberculosis; Tuberculin; Attenuated vaccine; Biology; Virology; Immunization; Immunology; Vaccination; Microbiology; Medicine; Immune system; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.07193749844206884,"gpt":0.4067609517440112,"spread":0.3348234533019423,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007475646,0.0005306036,0.002697941,0.0004648005,0.000129509,0.00001587771,0.0001234339,0.0003772605,0.0001045796],"category_scores_gemma":[0.0006734391,0.0002997066,0.0003589104,0.0002403472,0.00003486685,0.00005836947,0.00007643717,0.0005498187,0.00001187872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001106407,"about_ca_system_score_gemma":0.0001101929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007719838,"about_ca_topic_score_gemma":0.00001907688,"domain_scores_codex":[0.9976784,0.0004198962,0.000765851,0.0005724476,0.0001795127,0.0003838786],"domain_scores_gemma":[0.9981051,0.0006470745,0.0004059918,0.000463174,0.0001527817,0.0002258469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004194756,0.000170274,0.0001167318,0.006123851,0.0004974317,0.0000111602,0.00008736327,8.489038e-7,0.00007585792,0.000770767,0.0007029655,0.9910233],"study_design_scores_gemma":[0.01572769,0.03132204,0.3499225,0.08351453,0.005985622,0.001972817,0.0002676971,0.0001622396,0.0002241161,0.01792299,0.49015,0.002827709],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004426654,0.9912718,0.0000922516,0.0004156781,0.00003485159,0.003155239,0.00005874731,0.00005682921,0.0004879648],"genre_scores_gemma":[0.006744075,0.9923506,0.00007941185,0.0001035745,0.0002705088,0.00006862934,0.0001925833,0.0000525965,0.0001380348],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9881955,"threshold_uncertainty_score":0.9999455,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005791824","doi":"10.4161/hv.7.2.13690","title":"Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines","year":2011,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"GlaxoSmithKline","keywords":"Bivalent (engine); Immunogenicity; Medicine; Vaccination; Booster dose; Virology; Immune system; Cervical cancer; Immunology; HPV vaccines; HPV infection; Immunization; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1415539668768364,"gpt":0.3979404713217016,"spread":0.2563865044448651,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000766437,0.0006824392,0.002532723,0.0003582254,0.0003950828,0.00005047364,0.0004105663,0.0003119937,0.01146885],"category_scores_gemma":[0.00007744872,0.0003626544,0.000725159,0.000909271,0.00008961811,0.0001480631,0.0002069477,0.001193295,0.000244997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000196279,"about_ca_system_score_gemma":0.0002835219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000339739,"about_ca_topic_score_gemma":0.0006456065,"domain_scores_codex":[0.996698,0.0003666845,0.001124378,0.00072587,0.0005802354,0.0005048603],"domain_scores_gemma":[0.9971319,0.00006302959,0.0007269977,0.001151291,0.0007214746,0.0002053199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004882779,0.0002578278,0.001388785,0.353411,0.0003048029,0.00001082238,0.0000243128,1.699808e-8,0.000006818961,0.00007526066,0.0067358,0.6377357],"study_design_scores_gemma":[0.0009813838,0.0007851568,0.01362117,0.1026159,0.002372902,0.0001006059,0.000003107879,3.495817e-7,0.00002006174,0.0000156168,0.8790507,0.0004329976],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002760993,0.9824143,0.00000905551,0.00008839792,0.0001301442,0.004350822,0.00001413394,0.0001193495,0.01259767],"genre_scores_gemma":[0.0003104319,0.9941375,0.000005664655,0.0001557804,0.001068359,0.0009876369,0.0003132438,0.0001271834,0.002894199],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8723149,"threshold_uncertainty_score":0.9998825,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035983041","doi":"10.4161/hv.4.3.5686","title":"The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia","year":2008,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Université Laval","funders":"Merck Canada; Université Laval; GlaxoSmithKline","keywords":"Medicine; Vaccination; Cost effectiveness; Population; Quality-adjusted life year; Vaccine efficacy; Pediatrics; Cohort; Environmental health; Immunology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02385517260711885,"gpt":0.2980076727560617,"spread":0.2741525001489428,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000148475,0.0001464078,0.0002256357,0.00008611475,0.0004494477,0.00001858764,0.00004945159,0.00006141929,0.00006890906],"category_scores_gemma":[0.00004403818,0.00009408582,0.00008038751,0.000116082,0.00004190423,0.00009717994,0.00003582499,0.00007662241,0.00001375577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003501078,"about_ca_system_score_gemma":0.00002816585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007179486,"about_ca_topic_score_gemma":0.0000314619,"domain_scores_codex":[0.9991891,0.0001069927,0.0002202161,0.0001874582,0.000130136,0.0001661049],"domain_scores_gemma":[0.9992961,0.0001161143,0.00008210402,0.0002287491,0.000211922,0.00006499697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001840304,0.00196054,0.3540874,0.0008342934,0.0009973181,0.0003726932,0.0008746227,0.00006833343,0.06218709,0.001104954,0.0009473156,0.5747251],"study_design_scores_gemma":[0.002673463,0.0003270605,0.9879035,0.0000695278,0.0001041665,0.0001745105,0.00004682219,0.00007055566,0.005666825,0.0001115252,0.002758601,0.00009341606],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973449,0.0004870843,0.00002745032,0.0001689317,0.0001414365,0.0006692912,0.000005126427,0.00004333356,0.001112434],"genre_scores_gemma":[0.9988145,0.0002812071,0.00002380775,0.00006155784,0.00007555974,0.00005921907,0.00002445451,0.00002088378,0.0006387778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6338161,"threshold_uncertainty_score":0.3836708,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152769327","doi":"10.4161/hv.5.5.7607","title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","year":2009,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Vaccination; Cutaneous leishmaniasis; Immunology; Leishmaniasis; Immunity; Leishmania; Leishmania major; Immune system; Medicine; Virology; Attenuated vaccine; Disease; Biology; Virulence","retraction":null,"screen_n_in":null,"score":{"opus":0.07216413609611459,"gpt":0.3886635933351086,"spread":0.316499457238994,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004792865,0.001430956,0.004397137,0.001317467,0.000955209,0.0005250556,0.0005775907,0.0006562547,0.0004016501],"category_scores_gemma":[0.0002945029,0.001126755,0.0007757366,0.000723,0.00006806239,0.0004699574,0.0003781636,0.001140722,0.0001251377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004604435,"about_ca_system_score_gemma":0.0003298491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006366405,"about_ca_topic_score_gemma":0.0003804029,"domain_scores_codex":[0.9947326,0.0003183968,0.001648027,0.001456028,0.0008154599,0.001029479],"domain_scores_gemma":[0.9967033,0.0003147869,0.0007569316,0.001231582,0.0005958175,0.0003975675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003021618,0.0003419474,0.0002589724,0.02513687,0.0009338366,0.000825137,0.0001967121,5.91249e-7,0.00003804998,0.001963098,0.01779872,0.9524758],"study_design_scores_gemma":[0.001552627,0.001104094,0.004373088,0.01152907,0.001972256,0.001530383,0.0003549159,0.000003981919,0.000008150662,0.0009110977,0.9753947,0.001265663],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002898075,0.9764901,0.000003343801,0.0003255613,0.0001451532,0.002625598,0.00002725305,0.0004980412,0.01698683],"genre_scores_gemma":[0.002685926,0.9899409,0.000125828,0.0001229008,0.001507487,0.0002495291,0.0004734287,0.0002392668,0.004654728],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9575959,"threshold_uncertainty_score":0.999844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127650449","doi":"10.4161/hv.6.6.11097","title":"Recent advances in<i>Ebolavirus</i>vaccine development","year":2010,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Biodefense; Ebolavirus; Virology; Case fatality rate; Biology; Outbreak; Medicine; Immunology; Ebola virus; Population; Microbiology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.08233256001993501,"gpt":0.4332165868233698,"spread":0.3508840268034348,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000403151,0.0005353166,0.001931664,0.0008367022,0.0002044719,0.00005247562,0.0002298871,0.0004337735,0.001748919],"category_scores_gemma":[0.00009456889,0.0003782946,0.0002928885,0.000741538,0.00001960426,0.0001573278,0.0001675778,0.001404983,0.0004845897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002334068,"about_ca_system_score_gemma":0.0004863908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001488752,"about_ca_topic_score_gemma":0.000898966,"domain_scores_codex":[0.9973967,0.00008428993,0.001045196,0.0006020837,0.0003283363,0.0005433685],"domain_scores_gemma":[0.9987463,0.00006806065,0.0002395082,0.0005341461,0.0001921499,0.0002198488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001390046,0.0002014457,0.000204673,0.006060455,0.00004490843,0.000062638,0.00002124685,7.2091e-8,0.000008882072,0.00005621049,0.001043229,0.9922823],"study_design_scores_gemma":[0.0007519858,0.0001155659,0.0005244761,0.007197693,0.0001803812,0.0001788613,0.000007088363,5.679293e-7,0.00002219677,0.00001871275,0.9906381,0.0003643134],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001596816,0.9915809,0.000004671447,0.00006580944,0.0003661307,0.001218078,0.000005707964,0.00009799346,0.006501012],"genre_scores_gemma":[0.00001190884,0.9940721,0.0001682069,0.00006392891,0.0006864605,0.0003468653,0.0002683566,0.00009392511,0.004288269],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.991918,"threshold_uncertainty_score":0.9998669,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065739755","doi":"10.4161/hv.6.12.13399","title":"Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"GlaxoSmithKline","keywords":"Antibody; Medicine; Titer; Vaccination; Antibody titer; Immunology; Correlation","retraction":null,"screen_n_in":null,"score":{"opus":0.04030643000301119,"gpt":0.3432970642834369,"spread":0.3029906342804257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005897452,0.0002803038,0.000664813,0.0004652191,0.0002544839,0.00006071484,0.0001173235,0.0001636763,0.004143672],"category_scores_gemma":[0.00006309263,0.0001927673,0.000028328,0.0005256867,0.000113179,0.0002099016,0.0001633837,0.0006991997,0.000001968729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007729461,"about_ca_system_score_gemma":0.0000555033,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009964056,"about_ca_topic_score_gemma":0.01235069,"domain_scores_codex":[0.9982532,0.0001025793,0.0004772122,0.0004409637,0.000283256,0.0004428095],"domain_scores_gemma":[0.998933,0.0001780029,0.0001368902,0.0003333379,0.000237259,0.0001814754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004070461,0.00009965256,0.9822082,0.000356479,0.00006061839,0.00001527704,0.001356011,0.000001068718,0.004480107,0.0002939558,0.0001872277,0.01053437],"study_design_scores_gemma":[0.007681533,0.0008558283,0.9880274,0.00007146372,0.00007490351,0.00003885987,0.0006837306,0.00006821035,0.0007482207,0.001313353,0.000223295,0.0002132183],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995102,0.000722482,0.00001383783,0.0009070182,0.0000233522,0.000698136,0.00004498367,0.00003636028,0.002451784],"genre_scores_gemma":[0.9989173,0.0001474644,0.00002142968,0.00009399535,0.0001376502,0.00004192966,0.00006770295,0.00003567262,0.0005368299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01135428,"threshold_uncertainty_score":0.9967667,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164293944","doi":"10.4161/hv.7.5.14819","title":"Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe","year":2011,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Inro Consultants (Canada)","funders":"","keywords":"Rotavirus; Rotavirus gastroenteritis; Medicine; Population; Virology; Pediatrics; Geography; Environmental health; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.09505753528006307,"gpt":0.3736135117448424,"spread":0.2785559764647794,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004019316,0.0002455445,0.001309134,0.0004202979,0.00002342365,0.00001223641,0.0002111451,0.0001112779,0.0000653725],"category_scores_gemma":[0.0001521183,0.0001634978,0.0001433483,0.0002448492,0.00002832487,0.00005853172,0.0001046199,0.0004211893,0.000006761825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003388464,"about_ca_system_score_gemma":0.00002632117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001590834,"about_ca_topic_score_gemma":0.000461987,"domain_scores_codex":[0.9976981,0.0005685465,0.0008379122,0.0003046836,0.0001250067,0.0004657336],"domain_scores_gemma":[0.9993446,0.0000261095,0.0002353039,0.0002694037,0.00003435107,0.00009017457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009532889,0.0001211866,0.7709301,0.01124795,0.00002733959,0.0002179447,0.0001923779,4.742662e-7,0.000001279227,0.00005821426,0.0002690725,0.2168388],"study_design_scores_gemma":[0.001742272,0.0011534,0.9377046,0.008382153,0.0002671946,0.0006767833,0.00004874143,0.00001194929,2.900352e-8,0.00005134128,0.04978366,0.0001778662],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1988647,0.800083,0.000001657614,0.00004215508,0.00005112919,0.000765495,0.00001860977,0.000008146447,0.0001650737],"genre_scores_gemma":[0.110058,0.889213,0.00002757134,0.00002511679,0.0003875857,0.00004760609,0.0001226029,0.00002681493,0.00009170658],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2166609,"threshold_uncertainty_score":0.6667246,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014047240","doi":"10.4161/hv.6.9.11561","title":"Recent advances in the development of novel mucosal adjuvants and antigen delivery systems","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Canada; Institute for Biological Sciences; Brock University","funders":"","keywords":"Adjuvant; Medicine; Mucosal immunity; Immunization; Immunology; Mucosal immunology; Vaccination; Vaccine adjuvant; Immune system; Antigen; Immunity","retraction":null,"screen_n_in":null,"score":{"opus":0.0213545117109131,"gpt":0.2824016329974406,"spread":0.2610471212865275,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001663835,0.00009057227,0.0001027744,0.0000363223,0.00005798689,0.00001489069,0.0001732139,0.00006153647,0.00001124827],"category_scores_gemma":[0.00001647331,0.00006330403,0.00001769728,0.00004010531,0.00002195447,0.000006666151,0.00005788813,0.00006361832,0.000001478505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001937018,"about_ca_system_score_gemma":0.00003058798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000101153,"about_ca_topic_score_gemma":0.001029373,"domain_scores_codex":[0.9994204,0.00001657637,0.0002098291,0.0001671917,0.00007056236,0.0001154106],"domain_scores_gemma":[0.9996647,0.000007754528,0.0000663748,0.0001703925,0.00007089508,0.00001988767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0000350208,0.0000922092,0.03219146,0.00003263416,0.00001541318,9.374171e-7,0.000372691,0.000009922883,0.9447478,0.00006847135,0.000297858,0.02213555],"study_design_scores_gemma":[0.001803787,0.000335104,0.5107375,0.00008389581,0.00001686601,0.00004241271,0.001904704,0.00009919944,0.3010763,0.00003957141,0.1834131,0.0004476858],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927437,0.006414437,0.00004714641,0.00002033775,0.0001789742,0.0001151207,0.000004330514,0.000002785466,0.0004731981],"genre_scores_gemma":[0.997203,0.002313796,0.00023251,0.00003739722,0.000112807,0.00001375205,0.00002651609,0.000006019593,0.00005423291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6436716,"threshold_uncertainty_score":0.2581463,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000061294","doi":"10.4161/hv.7.7.15579","title":"Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; University of California, San Francisco","keywords":"Medicine; Reactogenicity; Tolerability; Placebo; Adverse effect; Vaccination; Internal medicine; Incidence (geometry); Randomized controlled trial; Immunology; Immunogenicity; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.04165342418886398,"gpt":0.3194257755927847,"spread":0.2777723514039208,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002827598,0.0002287535,0.0005510631,0.0001560421,0.0001239275,0.00001545275,0.0001215815,0.0001062244,0.002143592],"category_scores_gemma":[0.00004467895,0.0001906653,0.000072721,0.0001909623,0.00006061287,0.0001319008,0.0001858591,0.0002319849,0.000006652257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006947567,"about_ca_system_score_gemma":0.00002340234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004209978,"about_ca_topic_score_gemma":0.008962378,"domain_scores_codex":[0.9982381,0.00007294807,0.0005561634,0.0004440866,0.0002882914,0.0004004002],"domain_scores_gemma":[0.9990914,0.00002304538,0.0001069021,0.0003778586,0.000158262,0.0002425361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002152388,0.0005802037,0.9814517,0.0006978841,0.00004101347,0.00002898141,0.001539012,8.076877e-8,0.007274747,0.0002789414,0.000271854,0.005683136],"study_design_scores_gemma":[0.009214015,0.0004883719,0.9816706,0.0002636851,0.00007789763,0.00002192123,0.000220294,0.00003139191,0.007410102,0.000253775,0.000160883,0.0001871092],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955656,0.001600124,0.000004571046,0.00007951015,0.00004989204,0.0005666394,0.00001074558,0.00003922795,0.002083693],"genre_scores_gemma":[0.9988372,0.0004270701,0.00002577766,0.0001080898,0.0001028789,0.00001877597,0.00001889573,0.0000315842,0.0004297573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007061626,"threshold_uncertainty_score":0.9987686,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048546608","doi":"10.4161/hv.6.8.12299","title":"Development of a Chlamydia trachomatis T cell Vaccine","year":2010,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Centre for Disease Control","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Chlamydia trachomatis; Immunology; Immunity; Antigen; Chlamydia; Biology; Immune system; Intracellular parasite; Virology; Cellular immunity; Acquired immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.06287883281366984,"gpt":0.367043941580649,"spread":0.3041651087669791,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005460706,0.0005033104,0.001810763,0.0006809238,0.0003190725,0.00001978051,0.0006019603,0.0008193461,0.003840217],"category_scores_gemma":[0.0001187191,0.0003887836,0.0003931059,0.0003817502,0.00005353714,0.00008517618,0.0001884446,0.001359441,0.001850498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007078572,"about_ca_system_score_gemma":0.0003869881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002285638,"about_ca_topic_score_gemma":0.00008977175,"domain_scores_codex":[0.9974378,0.0002428595,0.001178586,0.0006384157,0.00006574845,0.000436637],"domain_scores_gemma":[0.9979663,0.0002000587,0.000617863,0.0009561174,0.0002272888,0.00003233171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000007181322,0.0004631836,0.00008892701,0.007783783,0.0003442058,0.00000277607,0.0002308521,4.08752e-8,0.0118493,0.0001139124,0.001981366,0.9771345],"study_design_scores_gemma":[0.0004394477,0.00004016565,0.001370872,0.001166503,0.0002623376,0.000105161,0.00001500767,1.016089e-8,0.005607189,0.00001684524,0.9906321,0.0003443222],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007632534,0.9872453,0.00001118493,0.000003825758,0.0006241028,0.0009866374,0.00002589431,0.00008972078,0.003380823],"genre_scores_gemma":[0.0003749709,0.987729,0.0005673268,0.000002126985,0.000168278,0.0002968193,0.0004641839,0.00009016032,0.01030709],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9886508,"threshold_uncertainty_score":0.9998564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085552858","doi":"10.4161/hv.5.5.7442","title":"Vaccines targeting IgE in the treatment of asthma and allergy","year":2009,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; Manitoba Health","funders":"","keywords":"Omalizumab; Immunoglobulin E; Medicine; Asthma; Immunology; Allergy; Anaphylaxis; Adverse effect; Antibody; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.04369772046502389,"gpt":0.3482757917900099,"spread":0.304578071324986,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001265507,0.0004415016,0.001670058,0.0002588905,0.0000928618,0.00001835464,0.0001465863,0.0001715177,0.0001334809],"category_scores_gemma":[0.00003125698,0.0002222622,0.0004034484,0.0002209204,0.00002267463,0.00003611818,0.00002019805,0.0001245716,0.000007448705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004324269,"about_ca_system_score_gemma":0.00009337354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002919226,"about_ca_topic_score_gemma":0.00005282274,"domain_scores_codex":[0.9983764,0.0001589654,0.0006926823,0.0003552083,0.0001702621,0.0002465422],"domain_scores_gemma":[0.9990522,0.0001186303,0.0002971886,0.0003955858,0.00004996657,0.00008647473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002411105,0.0006368409,0.0006386194,0.004850276,0.0001245152,0.0001387776,0.0002935163,2.707007e-7,0.000003148407,0.00007647677,0.001752643,0.9914608],"study_design_scores_gemma":[0.000911661,0.0009752649,0.006419618,0.003880618,0.0003905724,0.00006112645,0.0001234357,7.326288e-7,0.000001706148,0.00002402732,0.9870192,0.0001920719],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007362255,0.9910706,3.693411e-7,0.00005520285,0.00005139847,0.0008383278,0.00001029451,0.0000265243,0.0005849915],"genre_scores_gemma":[0.0008952889,0.9975804,0.00002383146,0.00007142355,0.0007234514,0.0000754698,0.0001119261,0.00003837553,0.0004798326],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9912688,"threshold_uncertainty_score":0.9063588,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2064091377","doi":"10.4161/hv.1.1.1553","title":"A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Reactogenicity; Immunogenicity; Medicine; Virology; Nasal administration; Trivalent influenza vaccine; Influenza vaccine; Virus; Influenza A virus; Randomized controlled trial; Immunology; Internal medicine; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.07541509844375696,"gpt":0.4265677087669303,"spread":0.3511526103231734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003657291,0.0004480741,0.003174375,0.000589075,0.0002983069,0.00003238151,0.0002854458,0.0001115161,0.0001500312],"category_scores_gemma":[0.005600713,0.0002617136,0.000381668,0.0006413393,0.00008490907,0.000148012,0.0002897584,0.0005353517,0.00001019891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001833237,"about_ca_system_score_gemma":0.0001805784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002380748,"about_ca_topic_score_gemma":0.001640514,"domain_scores_codex":[0.994923,0.001127221,0.002146512,0.0005518168,0.0006681826,0.0005832781],"domain_scores_gemma":[0.9966252,0.001328269,0.000543299,0.0007297595,0.0005083308,0.0002651724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9754758,0.007581684,0.002192674,0.00006836101,0.001377769,0.00001483253,0.005188469,0.00000991312,0.006626958,0.00002569624,0.0001336807,0.001304152],"study_design_scores_gemma":[0.9714593,0.01072245,0.01374713,0.0001037874,0.0004461288,0.000006925346,0.001014072,0.0001426944,0.001869737,0.00002023465,0.0002537167,0.0002138004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9721219,0.004230401,0.000004114399,0.001160611,0.0000688836,0.02224202,0.00001454488,0.000060667,0.00009686931],"genre_scores_gemma":[0.9958625,0.0004128961,0.00004396294,0.001214126,0.0003024638,0.002088883,0.000004168991,0.00003817627,0.00003286009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02374058,"threshold_uncertainty_score":0.9999835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2416299241","doi":"10.4161/hv.7.0.14904","title":"Preface: Seventh World Congress on Vaccines, Immunisation and Immunotherapy","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"International Civil Aviation Organization","funders":"","keywords":"Library science; Vaccination; Medicine; Political science; Family medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.05717104425724771,"gpt":0.3054764996989979,"spread":0.2483054554417502,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001534244,0.0002359256,0.000372455,0.0002210346,0.0002533869,0.0000213531,0.00009645909,0.0000589349,0.001125323],"category_scores_gemma":[0.00003599574,0.0001915439,0.00006020775,0.0001481764,0.00003501297,0.0001137864,0.00005838935,0.0001652324,0.00007248173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004742962,"about_ca_system_score_gemma":0.00001971312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000746644,"about_ca_topic_score_gemma":0.001590531,"domain_scores_codex":[0.9989353,0.00005439365,0.0003156537,0.0002832219,0.0001637271,0.0002476401],"domain_scores_gemma":[0.9992225,0.00004762145,0.0001175648,0.0004227095,0.0001154003,0.00007419784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007645889,0.0004730992,0.9528216,0.0001607505,0.0003956107,0.0000406265,0.0040436,4.784342e-7,0.01149217,0.004001442,0.01408327,0.01172274],"study_design_scores_gemma":[0.002469336,0.0004905154,0.9765942,0.0001845447,0.00006280901,0.00001693904,0.00009141232,0.000009777435,0.005802834,0.0006402754,0.01342768,0.0002096424],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822674,0.001418195,0.000004584662,0.0003043626,0.0003223624,0.0005166557,0.000005428092,0.000150295,0.01501068],"genre_scores_gemma":[0.9867547,0.0006430802,0.0002411725,0.0005170078,0.0001753769,0.00005786981,0.00001931522,0.00004662588,0.01154482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02377261,"threshold_uncertainty_score":0.9997878,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087412934","doi":"10.4161/hv.1.5.2079","title":"Safety and Immunogenicity of a Pentavalent Combination Vaccine (Diphtheria, Tetanus, Acellular Pertussis, Polio and Haemophilus Influenzae Type b Conjugate) When Administered as a Fourth Dose at 15 to 18 Months of Age","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"BC Children's Hospital","funders":"Sanofi Pasteur","keywords":"Medicine; Tetanus; Diphtheria; Booster dose; Poliomyelitis; Vaccination; Immunogenicity; Immunization; Immunology; Vaccination schedule; Adverse effect; Conjugate vaccine; Haemophilus influenzae; Hib vaccine; Pediatrics; Internal medicine; Antibody; Antibiotics","retraction":null,"screen_n_in":null,"score":{"opus":0.02343117416936941,"gpt":0.2751080324284326,"spread":0.2516768582590632,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002160804,0.0002796797,0.000616849,0.00021455,0.0002583569,0.00002305733,0.0001572189,0.000200054,0.001854263],"category_scores_gemma":[0.0000706772,0.000243685,0.00008569691,0.0001364237,0.00005825968,0.0001413685,0.0002763696,0.000107115,0.00003013619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005255725,"about_ca_system_score_gemma":0.00003051844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001239206,"about_ca_topic_score_gemma":0.001524852,"domain_scores_codex":[0.9985306,0.0001484283,0.0006774739,0.0003463319,0.00003497964,0.0002622082],"domain_scores_gemma":[0.9989929,0.00006763128,0.0003044459,0.0003801176,0.0001954307,0.00005944552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002831224,0.0003610014,0.02626467,0.00009109688,0.0003324339,0.000002694169,0.001637896,0.000005622634,0.9649233,0.0005296973,0.001058388,0.001962034],"study_design_scores_gemma":[0.01279883,0.002941543,0.7311032,0.0001907422,0.0003716198,0.0003022986,0.0003116589,0.00001337226,0.1847556,0.0003779228,0.06623644,0.0005967672],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934267,0.004938547,0.000004992427,0.0004270691,0.0002291891,0.0005746875,0.00005820011,0.00003898476,0.0003015845],"genre_scores_gemma":[0.9966499,0.0004411299,0.0000690407,0.00009928285,0.00005797257,0.00001262789,0.0001129816,0.00002727554,0.002529746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7801676,"threshold_uncertainty_score":0.9990582,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049906117","doi":"10.4161/hv.5.3.7557","title":"AIDS Vaccine 2008 Conference","year":2009,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University","funders":"","keywords":"Hogan; Library science; Human immunodeficiency virus (HIV); Political science; Government (linguistics); Medicine; Family medicine; Sociology","retraction":null,"screen_n_in":null,"score":{"opus":0.03707829232206501,"gpt":0.3262082186977579,"spread":0.2891299263756929,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002833406,0.0001647281,0.0002456231,0.0001172894,0.0008215999,0.0001371682,0.0003966176,0.0001018953,0.004448519],"category_scores_gemma":[0.0001031219,0.0001551028,0.00009056945,0.0003002292,0.000005908603,0.0003957925,0.0000264467,0.0001370123,0.0002639368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004301792,"about_ca_system_score_gemma":0.00008771269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002816054,"about_ca_topic_score_gemma":0.001705094,"domain_scores_codex":[0.9986739,0.00008649896,0.0002648793,0.0002838774,0.0002531338,0.0004376936],"domain_scores_gemma":[0.9992211,0.00003955454,0.00008845776,0.0002931222,0.0001976718,0.0001600489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","study_design_scores_codex":[0.00006218925,0.0003488256,0.1243658,0.00001958009,0.00003907808,0.0000802174,0.01180903,0.000005518509,0.004667221,0.5364044,0.2820002,0.04019799],"study_design_scores_gemma":[0.001730412,0.0005250241,0.6799223,0.00007133666,0.00005446135,0.000006747094,0.001891035,0.00001005493,0.0006410137,0.07091212,0.2435496,0.0006859495],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8549465,0.0007912811,0.0001514295,0.006504696,0.0002680723,0.0002577366,0.000002408575,0.0003249956,0.1367529],"genre_scores_gemma":[0.9825321,0.000222737,0.0001729843,0.0009573995,0.00106506,0.000005593307,0.000007420007,0.0000106075,0.01502613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5555565,"threshold_uncertainty_score":0.9964616,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992463335","doi":"10.4161/hv.6.4.10867","title":"Development of TNFSF as molecular adjuvants for ALVAC HIV-1 vaccines","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Immunogenicity; Medicine; HIV vaccine; Adjuvant; Vaccination; Clinical trial; Immunology; AIDS Vaccines; Vaccine trial; Virology; Human immunodeficiency virus (HIV); Immune system; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01878471756305687,"gpt":0.3033413365913008,"spread":0.2845566190282439,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001569879,0.0001896828,0.0002943196,0.0001352291,0.0002438694,0.00001045844,0.0002623346,0.0001517045,0.001867905],"category_scores_gemma":[0.0000841705,0.0001504493,0.0001031058,0.00007084539,0.00003407228,0.00005165609,0.00008870576,0.0001593653,0.001131568],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001334026,"about_ca_system_score_gemma":0.0001021695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001843389,"about_ca_topic_score_gemma":0.0002150954,"domain_scores_codex":[0.9989218,0.00003245299,0.0003277368,0.0002802972,0.00004332145,0.0003944069],"domain_scores_gemma":[0.9993097,0.00006752332,0.00009734794,0.0003264339,0.0001550543,0.00004393057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001312701,0.0002546653,0.004317332,0.00005449683,0.0002789875,0.000006736181,0.0003677666,3.928074e-7,0.9761345,0.001691838,0.007559187,0.009202765],"study_design_scores_gemma":[0.003269078,0.0002039793,0.02553253,0.0000248368,0.00003961206,0.00002378188,0.0001050278,5.748508e-7,0.8090677,0.0004424841,0.1611027,0.0001877544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968717,0.0006593166,0.0001428821,0.0002003166,0.0002925757,0.0004739941,0.0000544883,0.00005108671,0.001253686],"genre_scores_gemma":[0.9903173,0.0000118056,0.002918447,0.00004295509,0.00004715098,0.0001587828,0.0005122182,0.0000253391,0.005966017],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1670669,"threshold_uncertainty_score":0.9996462,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086311575","doi":"10.4161/hv.1.6.2377","title":"Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-<i>Haemophilus influenzae</i>b Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Diphtheria; Immunogenicity; Medicine; Virology; Tetanus; Haemophilus influenzae; Conjugate vaccine; Poliovirus; Immunization; Vaccination; Microbiology; Immunology; Antibody; Antibiotics; Virus; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02027294642395011,"gpt":0.2904327260510381,"spread":0.270159779627088,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003065908,0.0004305523,0.001245699,0.0004991452,0.0001864973,0.00001581173,0.0001955083,0.0001279496,0.0004600503],"category_scores_gemma":[0.0002428927,0.0003927993,0.0001715449,0.0005949253,0.0000649084,0.0002466193,0.0002459237,0.0002277496,0.00001386847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002137759,"about_ca_system_score_gemma":0.00006577297,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0264366,"about_ca_topic_score_gemma":0.01991738,"domain_scores_codex":[0.9971969,0.0001098476,0.001364042,0.0004901753,0.0003597636,0.0004793429],"domain_scores_gemma":[0.9983025,0.0001118148,0.0003827415,0.0006701195,0.0003321582,0.0002006406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008687636,0.0004038386,0.8812279,0.0001129451,0.0003378343,0.00001026507,0.001529984,0.0001276668,0.1135983,0.0005188649,0.0002032669,0.001060354],"study_design_scores_gemma":[0.007099909,0.0006393596,0.9501023,0.0003646834,0.0002129998,0.00003593424,0.00003656483,0.0001760556,0.04034373,0.0001555688,0.0005036038,0.0003292633],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945006,0.002532897,0.00004440204,0.0006253116,0.000046728,0.001403723,0.0001678427,0.00007269565,0.0006057739],"genre_scores_gemma":[0.9972704,0.0009656777,0.0008250346,0.0003490452,0.0001663307,0.00004972654,0.00006452185,0.00006666305,0.0002425888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07325457,"threshold_uncertainty_score":0.9998524,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970117165","doi":"10.4161/hv.6.2.10299","title":"Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Institut National de Santé Publique du Québec","funders":"Merck Canada","keywords":"Titer; Medicine; Vaccination; Booster dose; Booster (rocketry); Hepatitis B; Persistence (discontinuity); Hepatitis B vaccine; Immunology; Antibody; Immune system; Immunological memory; Immunity; Internal medicine; Hepatitis B virus; HBsAg; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01043986601486147,"gpt":0.2668096234414044,"spread":0.2563697574265429,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001616795,0.0002256808,0.0007125677,0.0001968254,0.00009005341,0.000009921991,0.0001002951,0.00008488519,0.0003152731],"category_scores_gemma":[0.00008419227,0.0001711642,0.00009624097,0.0001760974,0.00005169739,0.0001650427,0.00009131732,0.0001863646,0.000003719566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001614664,"about_ca_system_score_gemma":0.0000352873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009978043,"about_ca_topic_score_gemma":0.004168581,"domain_scores_codex":[0.9987066,0.00003320992,0.0004937856,0.0003013056,0.0002470284,0.0002180353],"domain_scores_gemma":[0.9987112,0.00004651184,0.0002809589,0.0004217331,0.0004629843,0.00007662061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003141044,0.0003272315,0.865602,0.0009459445,0.00032451,0.00002111149,0.000843108,2.433619e-7,0.1305309,0.00003784911,0.00005612633,0.0009968642],"study_design_scores_gemma":[0.002205165,0.0007629496,0.956381,0.0004639689,0.0006584718,0.000049251,0.0001001624,0.00002010352,0.03911109,0.00005961899,0.00002373264,0.0001645279],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975705,0.001006322,0.00001385776,0.0001768527,0.000164253,0.0005300859,0.00001114251,0.00003494253,0.0004920009],"genre_scores_gemma":[0.9983955,0.0005048833,0.0004534782,0.00003716474,0.0000614078,0.0000282594,0.00003048289,0.00003258988,0.0004562073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09141985,"threshold_uncertainty_score":0.6979872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074911236","doi":"10.4161/hv.4.1.4778","title":"Antibody gene-based prophylaxis and therapy for biodefence","year":2008,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Bacillus and Francisella bacterial research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Antibody; Genetic enhancement; Immunology; Passive immunity; Vaccination; Immunity; Immune system; Medicine; In vivo; Biology; Gene delivery; Transgene; Vectors in gene therapy; Virology; Gene; Vector (molecular biology); Biotechnology; Recombinant DNA; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03448213629659268,"gpt":0.3098413044306517,"spread":0.275359168134059,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008584635,0.0001061999,0.0001057446,0.00003197776,0.0002221157,0.00001877346,0.0001076481,0.00008357891,0.00002627894],"category_scores_gemma":[0.00002762909,0.00008524757,0.00005119299,0.00004366528,0.00005685485,0.000002332639,0.00002858186,0.00003327362,0.00000263319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000002390267,"about_ca_system_score_gemma":0.00003962424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001450215,"about_ca_topic_score_gemma":0.00000668254,"domain_scores_codex":[0.9993641,0.00001869083,0.0001040713,0.0002619473,0.00006360243,0.0001875271],"domain_scores_gemma":[0.9995964,0.000008938227,0.00002900105,0.0002037428,0.0001058071,0.00005611642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001778568,0.00004097242,0.01311806,0.00001694338,0.00001089406,0.00000141097,0.00001851361,0.000001177946,0.983502,0.00001545002,0.0002880251,0.002808644],"study_design_scores_gemma":[0.002255593,0.001760965,0.06936721,0.000006307391,0.000003394588,0.00001430549,0.000005907149,0.00004442841,0.8847071,0.00009850069,0.04148731,0.0002490038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966199,0.001764891,0.001059294,0.00004648064,0.00005147231,0.0003075274,0.00002142757,0.000009960228,0.000119094],"genre_scores_gemma":[0.9977195,0.000766163,0.0004903573,0.00009963592,0.0002897339,0.00004107878,0.0001770713,0.00001685777,0.0003996142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09879497,"threshold_uncertainty_score":0.3476295,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035039470","doi":"10.4161/hv.1.4.1971","title":"Canadian Association for Immunization Research and Evaluation (CAIRE) Guidelines for Industry Sponsored Clinical Trial and Epidemiology Contract Research","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Wyeth Pharmaceuticals","keywords":"Epidemiology; Protocol (science); Clinical trial; Association (psychology); Medicine; Immunization; Family medicine; Public health; Environmental health; Business; Alternative medicine; Pathology; Immunology; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.70834095780831,"gpt":0.6420046208395551,"spread":0.06633633696875485,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","sts"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06487007,0.0001007449,0.0003271891,0.0003499004,0.002242139,0.0001298939,0.0001833151,0.0006749952,0.0001059731],"category_scores_gemma":[0.07679698,0.00009868356,0.00005864364,0.000274298,0.00004120707,0.0003201072,0.00003581137,0.0004670463,0.00000399841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006230219,"about_ca_system_score_gemma":0.001029158,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03542343,"about_ca_topic_score_gemma":0.5391774,"domain_scores_codex":[0.9950435,0.002705652,0.0007801095,0.0003924913,0.0003944808,0.0006837784],"domain_scores_gemma":[0.9859882,0.008295807,0.000199031,0.0001836007,0.00508462,0.0002487598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00384823,0.0001667341,0.6176642,0.00003582676,0.00009228384,6.518426e-7,0.002654935,0.00001767389,0.00007611942,0.06068343,0.2478762,0.06688375],"study_design_scores_gemma":[0.03255577,0.001381842,0.5632771,0.00007285846,0.00008535617,9.996614e-7,0.002280558,0.003049149,0.00001799312,0.06214332,0.3348252,0.0003098419],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9415568,0.001148716,0.00002490466,0.05334846,0.0002598667,0.00288319,0.00001738009,0.00002277327,0.000737943],"genre_scores_gemma":[0.9879069,0.0006686516,0.000625174,0.0003707603,0.005255096,0.0003607075,0.00008342847,0.00001871916,0.004710544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.503754,"threshold_uncertainty_score":0.9990568,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2091731210","doi":"10.4161/hv.6.10.13018","title":"Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas","year":2010,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Brock University","funders":"","keywords":"Dengue vaccine; Dengue fever; Context (archaeology); Clinical trial; Medicine; Meaning (existential); Dengue virus; Immunology; Psychology; Geography; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04870869317239846,"gpt":0.3570735335645766,"spread":0.3083648403921782,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009026963,0.0009007616,0.003765681,0.00149915,0.00008403631,0.00006010154,0.0004061332,0.000681363,0.0001044903],"category_scores_gemma":[0.001933369,0.0007538345,0.0005409498,0.0009165612,0.00001818608,0.0002738833,0.0002248036,0.0008852617,0.000002362273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000111762,"about_ca_system_score_gemma":0.0006349661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009927095,"about_ca_topic_score_gemma":0.0140245,"domain_scores_codex":[0.9944059,0.0002653462,0.003069804,0.001094731,0.0004397247,0.0007244707],"domain_scores_gemma":[0.9966028,0.0003301462,0.00108066,0.0009460754,0.0007077832,0.0003324973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.00546194,0.0022228,0.08708793,0.02162532,0.0004992785,0.0002233342,0.001513155,0.00002877017,0.001380579,0.0003248708,0.0006917045,0.8789403],"study_design_scores_gemma":[0.2775778,0.005899094,0.212053,0.1945372,0.01622868,0.001341706,0.003648592,0.003058451,0.002348584,0.0003860806,0.2759087,0.007012081],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3804542,0.6131048,0.00003408275,0.00007691174,0.0001958448,0.005945228,0.0001150403,0.0000480622,0.00002586029],"genre_scores_gemma":[0.5733636,0.4172054,0.0014992,0.0003291366,0.003290753,0.002032428,0.001410505,0.0004546008,0.0004143891],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.8719282,"threshold_uncertainty_score":0.9994913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2057104007","doi":"10.4161/hv.7.6.15007","title":"Increasing pandemic vaccination rates with effective communication","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Misinformation and Its Impacts","field":"Social Sciences","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Providence Health Care; Centre for Health Evaluation and Outcome Sciences","funders":"","keywords":"Public health; Pandemic; Public relations; Vaccination; Health communication; Information Dissemination; Social media; Internet privacy; Medicine; Business; Coronavirus disease 2019 (COVID-19); Political science; Disease; Infectious disease (medical specialty); Computer science; Immunology; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.05845645706609882,"gpt":0.3460264004311486,"spread":0.2875699433650498,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007996741,0.00007353094,0.00008767191,0.00008891244,0.0006885548,0.00006847773,0.0001618861,0.00004942685,0.0008754947],"category_scores_gemma":[0.0001824245,0.00005880857,0.00001810724,0.0001811329,0.00002733188,0.0007246903,0.0000200563,0.00007185528,0.00004820704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006148402,"about_ca_system_score_gemma":0.00002998103,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002242933,"about_ca_topic_score_gemma":0.002736105,"domain_scores_codex":[0.9992322,0.0002778112,0.0001308172,0.00007584964,0.0001381637,0.0001451848],"domain_scores_gemma":[0.9993953,0.0001039535,0.0001225942,0.0001598263,0.0001539057,0.00006443213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002071828,0.0001393443,0.4852336,0.00004945978,0.00005400011,0.000001009609,0.3820386,0.000004233344,0.0004781053,0.07715496,0.001816749,0.05282274],"study_design_scores_gemma":[0.000487656,0.00006391647,0.9861257,0.00003614793,0.00001385344,0.000003087788,0.008385431,0.00001734134,0.0003764642,0.001961316,0.002410822,0.000118233],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.874556,0.00009055019,0.00008726016,0.00008154012,0.00002547948,0.0002745702,4.707682e-7,0.0001235134,0.1247606],"genre_scores_gemma":[0.9989666,0.00011908,0.0003321246,0.0001040844,0.00005018223,0.000007268484,0.00001009109,0.000006852044,0.0004036657],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5008921,"threshold_uncertainty_score":0.9586053,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970168773","doi":"10.4161/hv.6.3.10298","title":"High titer human immunoglobulin as a specific therapy against West Nile virus encephalitis","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Japanese encephalitis; Virology; Disease; Immunology; Virus; Encephalitis; Asymptomatic; Population; Medicine; Antibody; Culex; Flavivirus; Biology; Environmental health; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01421354571300823,"gpt":0.2832275121112452,"spread":0.269013966398237,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001339724,0.0003302122,0.0004711068,0.0001285629,0.0003339148,0.000127938,0.000294895,0.0001484688,0.02022809],"category_scores_gemma":[0.00002116974,0.0002696295,0.0002593825,0.0001437771,0.00006062356,0.0001300842,0.00005596171,0.0003602843,0.0008699308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002848264,"about_ca_system_score_gemma":0.0000520051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006876906,"about_ca_topic_score_gemma":0.0003482193,"domain_scores_codex":[0.9982855,0.00003921282,0.0004411462,0.0004986082,0.0002982869,0.0004372845],"domain_scores_gemma":[0.9985182,0.00003087361,0.0001343656,0.0009063077,0.0001675386,0.0002426929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.000439568,0.0008399722,0.02664419,0.00004415353,0.0001782741,0.0002897021,0.0004128343,9.332214e-7,0.9132321,0.01078361,0.02384245,0.02329216],"study_design_scores_gemma":[0.007325019,0.0006402227,0.6951665,0.00009266896,0.00007044759,0.00005422694,0.0001359562,0.000005832173,0.01236074,0.001223219,0.2824289,0.0004962671],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885523,0.002246678,0.000003719957,0.0006479763,0.0005772305,0.0005513114,0.00003680757,0.0001876235,0.00719639],"genre_scores_gemma":[0.9884697,0.0004341856,0.00006583138,0.001693996,0.002431211,0.00009822255,0.0002405191,0.00006754023,0.006498799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9008714,"threshold_uncertainty_score":0.9999756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971945861","doi":"10.4161/hv.7.4.14141","title":"Acute otitis media and its prevention by immunization: A survey of Canadian pediatricians’ knowledge, attitudes and beliefs","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Institut National de Santé Publique du Québec","funders":"GlaxoSmithKline","keywords":"Medicine; Acute otitis media; Immunization; Otitis; Medical prescription; Family medicine; Pediatrics; Adverse effect; Multivariate analysis; Pneumococcal conjugate vaccine; Immunology; Antibiotics; Internal medicine; Streptococcus pneumoniae; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.05734017980258541,"gpt":0.3039299727532077,"spread":0.2465897929506223,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000135065,0.0001051256,0.0002023057,0.0003786084,0.0001637197,0.000009185832,0.00004336266,0.00008386913,0.0001791356],"category_scores_gemma":[0.00006934891,0.00009405566,0.00002304137,0.0003664577,0.00002691775,0.00009017038,0.00002476606,0.00007793331,0.000007075023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000157503,"about_ca_system_score_gemma":0.00009649807,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01356,"about_ca_topic_score_gemma":0.2482176,"domain_scores_codex":[0.9994018,0.00005637124,0.0002034343,0.0001467974,0.00005663617,0.0001349542],"domain_scores_gemma":[0.9993972,0.00003320797,0.00006643766,0.0001190573,0.0002197094,0.000164452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000092708,0.0001399752,0.9890853,0.0001452399,0.0001026799,0.000006639341,0.001179917,4.48803e-8,0.00584623,0.000314772,0.002706724,0.0004632481],"study_design_scores_gemma":[0.0006142535,0.000206906,0.9971221,0.00005979517,0.000111351,0.00003172647,0.00002137132,0.000002944085,0.0007633359,0.00003619754,0.0009395765,0.00009044224],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937403,0.003345782,0.000004226175,0.00008555825,0.0001201708,0.0001966586,0.00005976107,0.00002466166,0.002422934],"genre_scores_gemma":[0.9974321,0.00143309,0.00001373656,0.00004242461,0.00008137289,0.00000969241,0.00008590402,0.00001475851,0.0008869063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2346576,"threshold_uncertainty_score":0.9930088,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2043876053","doi":"10.4161/hv.6.12.12917","title":"Searching for the Holy Grail of a staphylococcal vaccine","year":2010,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Optech (Canada)","funders":"","keywords":"Holy Grail; Staphylococcus aureus; Immunology; Colonization; Medicine; Staphylococcal infections; Virology; Microbiology; Biology; Computer science; Bacteria","retraction":null,"screen_n_in":null,"score":{"opus":0.07428239513320778,"gpt":0.3965254161790951,"spread":0.3222430210458874,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000689831,0.000660249,0.002760671,0.0003785204,0.0003434351,0.00005473358,0.0007305444,0.0004792908,0.0002095688],"category_scores_gemma":[0.000484308,0.0003874522,0.001496186,0.0004553117,0.0001057493,0.00005910649,0.0001862816,0.001226794,0.00002384631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006389156,"about_ca_system_score_gemma":0.0004087444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005466439,"about_ca_topic_score_gemma":0.0001200955,"domain_scores_codex":[0.99714,0.00008920555,0.001218015,0.0006116494,0.0003494649,0.0005915993],"domain_scores_gemma":[0.9961755,0.001171473,0.0007790591,0.001308614,0.0004052322,0.0001601005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000168413,0.0001962901,0.00009081911,0.04278648,0.0006024228,0.0000186258,0.0001089952,3.555812e-7,0.001639105,0.002232932,0.01052699,0.9416286],"study_design_scores_gemma":[0.001112509,0.0002498647,0.0005884538,0.009715897,0.002248001,0.00005187152,0.00002959421,0.000003394719,0.00005722988,0.0001783075,0.9854121,0.0003528145],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001067115,0.9933428,0.0002284108,0.0001530867,0.0003646255,0.004188433,0.0001455239,0.0000820194,0.0004279876],"genre_scores_gemma":[0.0006616139,0.994238,0.0007689106,0.00007199588,0.001393978,0.0004114057,0.0001664072,0.0002042913,0.002083416],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.974885,"threshold_uncertainty_score":0.9998577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002056847","doi":"10.4161/hv.1.4.1990","title":"Potency of Cell-Mediated Immune Responses to Different Combined HIV-1 Immunogens in a Humanized Murine Model","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Potency; Humanized mouse; Immune system; Immunology; Human immunodeficiency virus (HIV); Virology; Biology; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.01942328443197603,"gpt":0.2721785256172667,"spread":0.2527552411852907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001687939,0.0002633123,0.000534413,0.0004361319,0.0001549414,0.00001042018,0.0003289856,0.0001327365,0.001367082],"category_scores_gemma":[0.0000750851,0.00021061,0.0001232287,0.0001860003,0.00006105219,0.00006007924,0.0001861208,0.0002162601,0.001051885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008941389,"about_ca_system_score_gemma":0.00005099061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000188017,"about_ca_topic_score_gemma":0.0003807118,"domain_scores_codex":[0.998322,0.000198238,0.0005762891,0.0003222745,0.00006426251,0.0005169375],"domain_scores_gemma":[0.9991338,0.0001257382,0.0001067392,0.0004833344,0.00009966783,0.00005076881],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001934176,0.001462542,0.01046372,0.00002928822,0.0001170449,0.00001419925,0.0009170432,0.00006713517,0.9830663,0.0001941765,0.001282374,0.0004520705],"study_design_scores_gemma":[0.02261445,0.001501305,0.4845993,0.0001172015,0.00007069053,0.00001552127,0.0002841381,0.0001678062,0.4882665,0.0002261711,0.00160465,0.0005322445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961052,0.001846243,0.00002352215,0.0005660444,0.00004929908,0.0005535248,0.0001475958,0.00006301541,0.0006455866],"genre_scores_gemma":[0.9816982,0.0001139273,0.000127804,0.00004075553,0.00001661344,0.0001012354,0.0005015914,0.00002705118,0.01737283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4947997,"threshold_uncertainty_score":0.9997259,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040474024","doi":"10.4161/hv.5.11.9309","title":"In Memoriam, Bernard Duval (1949 – 2008)","year":2009,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Travel-related health issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut National de Santé Publique du Québec","funders":"","keywords":"Philosophy; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02820136364870216,"gpt":0.3556224561238016,"spread":0.3274210924750994,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001935397,0.0001917737,0.0004119052,0.0002561069,0.00008698133,0.00001379707,0.0001155518,0.0001690821,0.00112178],"category_scores_gemma":[0.00006585541,0.0001703153,0.00006493389,0.0002511177,0.00001319273,0.0001171304,0.00001703816,0.0003704251,0.0003892726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009140871,"about_ca_system_score_gemma":0.00005609659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002025077,"about_ca_topic_score_gemma":0.0002063232,"domain_scores_codex":[0.9985723,0.00003515838,0.0004453545,0.0003004104,0.0002242804,0.0004225146],"domain_scores_gemma":[0.9992725,0.00002946994,0.00008082351,0.0003601228,0.00007277667,0.0001842787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.001080726,0.001707458,0.241017,0.0004921742,0.0001279155,0.002389231,0.006082148,0.00003846365,0.02219675,0.01310995,0.7019216,0.009836593],"study_design_scores_gemma":[0.003726524,0.0005875059,0.9291611,0.0002113423,0.0000481936,0.0001043512,0.00007423986,0.00002705556,0.001122191,0.002573298,0.0621594,0.0002047918],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9670622,0.001446545,0.000004296593,0.01611297,0.0008548796,0.0004393932,0.000001979185,0.0001799757,0.01389778],"genre_scores_gemma":[0.9851524,0.0001368548,0.0004548255,0.002478532,0.002001065,0.000009032287,0.00001629352,0.00002897673,0.009722006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6881441,"threshold_uncertainty_score":0.9997913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}